Welcome to our dedicated page for COEPW SEC filings (Ticker: COEPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on COEPW's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into COEPW's regulatory disclosures and financial reporting.
Z Squared Inc. director and Co-Chief Executive Officer Halabu David Elias filed an initial ownership report showing an indirect stake in the company’s common stock through SMSC Capital Holdings LLC. SMSC holds 1,412,855 shares of Z Squared common stock, received at the closing of a merger under an Agreement and Plan of Merger.
The filing explains that Halabu owns a 1% membership interest in SMSC, while the David E. Halabu Irrevocable Trust, for which he serves as trustee, owns the remaining 99%. Halabu expressly disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
Z Squared Inc. director and Co-Chief Executive Officer Halabu David Elias filed an initial ownership report showing an indirect stake in the company’s common stock through SMSC Capital Holdings LLC. SMSC holds 1,412,855 shares of Z Squared common stock, received at the closing of a merger under an Agreement and Plan of Merger.
The filing explains that Halabu owns a 1% membership interest in SMSC, while the David E. Halabu Irrevocable Trust, for which he serves as trustee, owns the remaining 99%. Halabu expressly disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
Z Squared Inc. filed an initial Form 3 identifying Bryan Eric Fuerst as a director of the company. This form serves as his initial statement as a reporting person for the issuer's equity securities. The filing does not list any transactions or current holdings in either non-derivative or derivative securities.
Z Squared Inc. filed an initial Form 3 identifying Bryan Eric Fuerst as a director of the company. This form serves as his initial statement as a reporting person for the issuer's equity securities. The filing does not list any transactions or current holdings in either non-derivative or derivative securities.
Z Squared Inc. director Kenneth Lyle Cooper has filed an initial Form 3, which is a statement of beneficial ownership for insiders. The available data show no reported transactions, share holdings, or derivative positions in this filing, indicating it is a baseline disclosure of status as a director.
Z Squared Inc. director Kenneth Lyle Cooper has filed an initial Form 3, which is a statement of beneficial ownership for insiders. The available data show no reported transactions, share holdings, or derivative positions in this filing, indicating it is a baseline disclosure of status as a director.
Z Squared Inc. disclosed an initial insider ownership report for Michelle Ellen Burke, who serves as both a director and Co-Chief Executive Officer. The Form 3 data provided does not list any equity transactions or derivative positions for her and shows no reported buys, sells, or gifts.
Z Squared Inc. disclosed an initial insider ownership report for Michelle Ellen Burke, who serves as both a director and Co-Chief Executive Officer. The Form 3 data provided does not list any equity transactions or derivative positions for her and shows no reported buys, sells, or gifts.
Coeptis Therapeutics Holdings Inc reported that Vanguard Capital Management beneficially owned 346,975 shares of common stock, representing 5.57% of the class. The filing shows Vanguard has sole dispositive power over 346,975 shares and sole voting power over 26,244 shares. The disclosure attributes holdings to Vanguard and affiliated divisions and notes the holdings may include shares held by Vanguard funds and managed accounts.
Coeptis Therapeutics Holdings Inc reported that Vanguard Capital Management beneficially owned 346,975 shares of common stock, representing 5.57% of the class. The filing shows Vanguard has sole dispositive power over 346,975 shares and sole voting power over 26,244 shares. The disclosure attributes holdings to Vanguard and affiliated divisions and notes the holdings may include shares held by Vanguard funds and managed accounts.
Z Squared, Inc. provided additional details on its previously announced business combination with Coeptis Therapeutics Holdings, Inc. and a related pro rata dividend distribution. The company confirmed that shareholders of record on January 2, 2026 will receive a stock dividend from its subsidiary, Coeptis Holdings, Inc.
Each holder of Z Squared common stock will receive one share of non-transferable Coeptis Holdings, Inc. common stock for every share of Z Squared common stock held. The distribution is being effected on April 27, 2026. Z Squared’s common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol “ZSQR” on the same date.
The company describes itself as a vertically integrated computing infrastructure business with advanced, distributed computing hardware across North Carolina, South Carolina, and Iowa, supported by power management, real-time analytics, and in-house repair capabilities aimed at operational efficiency and scalability.
Z Squared, Inc. provided additional details on its previously announced business combination with Coeptis Therapeutics Holdings, Inc. and a related pro rata dividend distribution. The company confirmed that shareholders of record on January 2, 2026 will receive a stock dividend from its subsidiary, Coeptis Holdings, Inc.
Each holder of Z Squared common stock will receive one share of non-transferable Coeptis Holdings, Inc. common stock for every share of Z Squared common stock held. The distribution is being effected on April 27, 2026. Z Squared’s common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol “ZSQR” on the same date.
The company describes itself as a vertically integrated computing infrastructure business with advanced, distributed computing hardware across North Carolina, South Carolina, and Iowa, supported by power management, real-time analytics, and in-house repair capabilities aimed at operational efficiency and scalability.
Coeptis Therapeutics Holdings, Inc. notified Nasdaq of the removal of its warrants from listing and registration under Section 12(b) via Form 25. The filing states the Exchange and the Issuer complied with rules governing voluntary withdrawal and Nasdaq certified its grounds for the Form 25 filing.
Coeptis Therapeutics Holdings, Inc. notified Nasdaq of the removal of its warrants from listing and registration under Section 12(b) via Form 25. The filing states the Exchange and the Issuer complied with rules governing voluntary withdrawal and Nasdaq certified its grounds for the Form 25 filing.
Coeptis Therapeutics Holdings, Inc. filed an 8-K announcing it has completed its business combination with Z Squared Inc. and the combined company has been renamed Z Squared Inc.
The company’s public shares are expected to begin trading on the Nasdaq Global Market under the new ticker symbol “ZSQR” on April 27, 2026. Following the transaction, Z Squared Opco Inc. became a wholly owned subsidiary, and former Z Squared Opco stockholders now own about 85% of the combined company, while legacy Coeptis stockholders own about 15%, with roughly 51.5 million common shares outstanding.
Coeptis Therapeutics Holdings, Inc. filed an 8-K announcing it has completed its business combination with Z Squared Inc. and the combined company has been renamed Z Squared Inc.
The company’s public shares are expected to begin trading on the Nasdaq Global Market under the new ticker symbol “ZSQR” on April 27, 2026. Following the transaction, Z Squared Opco Inc. became a wholly owned subsidiary, and former Z Squared Opco stockholders now own about 85% of the combined company, while legacy Coeptis stockholders own about 15%, with roughly 51.5 million common shares outstanding.
The Vanguard Group filed an Amendment No. 1 to its Schedule 13G/A reporting for Coeptis Therapeutics Holdings Inc. The amendment states beneficial ownership of 0 shares (0%) of Common Stock as disclosed, and explains an internal realignment of Vanguard subsidiaries effective January 12, 2026.
The Vanguard Group filed an Amendment No. 1 to its Schedule 13G/A reporting for Coeptis Therapeutics Holdings Inc. The amendment states beneficial ownership of 0 shares (0%) of Common Stock as disclosed, and explains an internal realignment of Vanguard subsidiaries effective January 12, 2026.